This report provides a detailed description of the current infectious diseases drugs market and highlights the existing and developing anti-infective agents used to ameloriate diseases’ afflications on humankind.
Online PR News – 30-September-2009 – – According to the World Health Organization (WHO), six infectious diseases—pneumonia, tuberculosis, diarrhoeal diseases, malaria, measles and HIV/AIDS—account for half of all premature deaths worldwide, killing mostly children and young adults. What’s more, threatening pandemics such as swine flu (H1N1 influenza A virus) are adding significant pressure to already strained healthcare budgets of governments around the world.
This report provides a detailed description of the current infectious diseases drugs market and highlights the existing and developing anti-infective agents used to ameloriate diseases’ afflications on humankind. Anti-infective agents include: anti-viral therapeutics, antibiotics, anti-fungal agents and prophylactic treatments such as vaccines. Particular attention is paid to the clinical market segment and the pharmaceutical/biotechnology companies involved in anti-infective agents, with specific emphasis on each company’s sales focus, product portfolio and R&D pipeline. To date, the most successful anti-infective agents target the human immunodeficiency virus (HIV, the virus that causes AIDS), the herpes virus (HSV-1 and HSV-2), bacterial infections and hepatitis C (HCV). A number of exciting novel anti-viral and antibiotic compounds are currently revolutionizing the infectious diseases drugs market, including Truvada and Valtrex, which are anti-HIV and anti-herpes therapies, respectively. Signicant resources are also being dedicated toward hepatitis A (HAV), hepatitis B (HBV) and Staph infections, including MRSA. What’s more, this study will examine the existing and developing anti-infective agents targeted at infectious diseases that continue to devastate developing countries, including: cholera, dengue fever, meningitis, rotavirus, typhoid, yellow fever and onchocerciasis (“river blindness”).
For more information, please visit :
Or email us at firstname.lastname@example.org or call +919272852585